SCHEMBL7947121

SCHEMBL7947121

Cc1ccccc1P(N1CCCC1)N1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
ACHE P22303 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.35
ADRB1 P08588 1/20 0.34
ALKBH5 Q6P6C2 1/20 0.34
FTO Q9C0B1 1/20 0.34
ALDH1A1 P00352 3/20 0.34
GAA P10253 3/20 0.34
NPC1 O15118 2/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ATM Q13315 1/20 0.34
PLA2G7 Q13093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7948067 0.98 L3MBTL1 (0.36) TSHRACHETDP1CYP2D6CYP2C19
SCHEMBL11571785 0.85 TSHR (0.36) TSHRACHETDP1CYP2D6CYP2C19
SCHEMBL11570019 0.82 CYP2A13 (0.47) TSHRTDP1CYP2C19ALDH1A1GAA
SCHEMBL31355198 0.74 KMT2A (0.32) TSHRCYP2C19ALDH1A1ATM
SCHEMBL11679024 0.70 CYP3A4 (0.39) TSHRTDP1CYP2D6CYP2C19ALDH1A1
SCHEMBL10914158 0.69 TSHR (0.47) TSHRACHETDP1HTTALKBH5
SCHEMBL6901641 0.68 KCNH2 (0.41) TSHRTDP1CYP2D6CYP2C19ALDH1A1
SCHEMBL3127305 0.68 TSHR (0.53) TSHRACHETDP1HTTALKBH5
SCHEMBL29357701 0.68 TSHR (0.53) TSHRACHETDP1HTTALKBH5
SCHEMBL4480 0.68 TSHR (0.53) TSHRACHETDP1HTTALKBH5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8487136-B2 Method for producing norbornene derivative NIPPON OIL CORPORATION (JP) 2013-07-16 US disclosed
US-8487136-B2 Method for producing norbornene derivative NIPPON OIL CORPORATION (JP) 2013-07-16 US disclosed
US-20100197970-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE NIPPON OIL CORPORATION (JP) 2010-08-05 US disclosed
US-20100197970-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE NIPPON OIL CORPORATION (JP) 2010-08-05 US disclosed
WO-2001007449-A1 PHOSPHINE/PALLADIUM COMPLEX CATALYSTS FOR ARYLATION OF OLEFINS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197970-A1 METHOD FOR PRODUCING NORBORNENE DERIVATIVE NR0B2, IGF1R, CPNE4 TSHR 837/4885ACHE 3536/4885TDP1 2451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.